FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Sun Pharmaceutical Industries Perampanel CIII Tablets Recall

Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
Jul 1, 2026
Recall ID
D-0628-2026
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Perampanel CIII Tablets starting Jun 17, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0628-2026 on Jul 1, 2026. Reason: Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets. Status: Ongoing.

Why it was recalled

Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.

Product description

Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6

Lot numbers, UPCs & expiration codes

Lot AE01763, Expires 9/30/2027.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0628-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jun 17, 2026
FDA report date
Jul 1, 2026
Quantity
3,456 30-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0628-2026, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
99256
Address
2 Independence Way
Code information
Lot AE01763, Expires 9/30/2027.
Postal code
08540-6620
Report date
Jul 1, 2026
Product type
Drugs
Recall number
D-0628-2026
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
3,456 30-count bottles
Reason for recall
Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 17, 2026
Initial firm notification
Letter
Center classification date
Jun 26, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0628-2026, published Jul 1, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls